3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
7
Genitourinary
3
Other solid neoplasm
1
CNS
1
Conditions
Childhood Solid Tumor
1
Interventions
pembrolizumab
9
Specimen Handling
7
tislelizumab
6
Pemetrexed
6
Cisplatin
6
Carboplatin
6
fludarabine
5
atezolizumab
5
Interviews as Topic
5
Injections
5
Cyclophosphamide
5
Bevacizumab
5
Platinum
4
Fluorouracil
4
Educational Status
4
Biopsy
4
Standard of Care
3
Practice Guidelines as Topic
3
Nivolumab
3
Methods
3
Magnetic Resonance Spectroscopy
3
Early Intervention, Educational
3
Cetuximab
3
1,2-diaminocyclohexaneplatinum II citrate
3
sintilimab
2
sacituzumab govitecan
2
fludarabine phosphate
2
X-Rays
2
Trastuzumab
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vinblastine
×
Other solid neoplasm
×
30 days
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled